Don't Quit on a Quitter: Helping Your Patient Stop Smoking
With November 2012 bringing the American Cancer Society’s 37th Great American Smokeout, nearly one-fifth of Americans continue to smoke cigarettes. The unmet tobacco-related goals of Healthy People 2010 have had to be reintroduced in hope of greater success for 2020. The primary care clinician must be aware of all the resources available to help smoking patients quit—and mindful of the clinician’s own role in that important effort.
12. Lancaster T, Hajek P, Stead LF, et al. Prevention of relapse after quitting smoking: a systematic review of trials. Arch Intern Med. 2006;166(8): 828-835.
13. Chapman S, MacKenzie R. The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med. 2010;7(2):e1000216.
14. Hung WT, Dunlop SM, Perez D, Cotter T. Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters. BMC Public Health. 2011;11:592.
15. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008;34(2):102-111.
16. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000146.
17. Robles GI, Singh-Franco D, Ghin HL. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations. Clin Ther. 2008;30(5):800-812.
18. Japuntich SJ, Piper ME, Leventhal AM, et al. The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. J Consult Clin Psychol. 2011;79(1):34-42.
19. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. Am J Prev Med. 2011;40 (4):472-475.
20. Tønnesen P, Lauri H, Perfekt R, et al. Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial. Eur Respir J. 2012;40(3):548-554.
21. Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J. Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev. 2012 Aug 15;8:CD007072.
22. Roddy E. Bupropion and other non-nicotine pharmacotherapies. BMJ. 2004;328(7438):
509-511.
23. Loh WY, Piper ME, Schlam TR, et al. Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res. 2012;14(2):131-141.
24. Bolt DM, Piper ME, Theobald WE, Baker TB. Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol. 2012;80(1):44-65.
25. McNeil JJ, Piccenna L, Ioannides-Demos LL. Smoking cessation: recent advances. Cardiovasc Drugs Ther. 2010;24(4):359-367.
26. Ebbert JO, Hays JT, Hurt RD. Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs. 2010;70(6):643-650.
27. Hajek P, McRobbie HJ, Myers KE, et al. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Arch Intern Med. 2011;171 (8):770-777.
28. Bentz CJ. Review: clonidine is more effective than placebo for long-term smoking cessation, but has side effects. ACP J Club. 2005;142(1):12.
29. Mooney ME, Reus VI, Gorecki J, et al. Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis. Clin Pharmacol Ther. 2008;83(3):436-442.
30. White AR, Rampes H, Liu JP, et al. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev. 2011;(1): CD000009.
31. Barnes J, Dong CY, McRobbie H, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2010;(10):CD001008.
